Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells

被引:394
作者
Duluc, Dorothee [1 ,10 ]
Delneste, Yves [1 ,10 ]
Tan, Fang [1 ,10 ]
Moles, Marie-Pierre [1 ,2 ,3 ,10 ]
Grimaud, Linda
Lenoir, Julien [1 ,2 ]
Preisser, Laurence
Anegon, Ignacio [4 ,5 ]
Catala, Laurent [6 ]
Ifrah, Norbert [2 ,3 ]
Descamps, Philippe [6 ]
Gamelin, Erick [1 ,7 ]
Gascan, Hugues [1 ]
Hebbar, Mohamed [8 ]
Jeannin, Pascale [1 ,9 ,10 ]
机构
[1] Univ Angers, Unite Rech Sante 564, Angers, France
[2] UPRES EA3863, Angers, France
[3] CHU Angers, Dept Malad Sang, Angers, France
[4] INSERM, UMR 643, Nantes, France
[5] Univ Nantes, Inst Transplantat & Rech Transplantat, FOCIS, Nantes, France
[6] CHU Angers, Dept Gynecol, Angers, France
[7] Ctr Lutte Contre Canc Paul Papin, Angers, France
[8] CHU Lille, Dept Oncol, F-59037 Lille, France
[9] CHU Angers, Lab Immunol & Allergol, Angers, France
[10] Ctr Hosp Univ, INSERM, Unit Equipe Avenir 564, F-49933 Angers, France
关键词
D O I
10.1182/blood-2007-02-072587
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Tumor-associated macrophages (TAMs), the most abundant immunosuppressive cells in the tumor microenvironment, originate from blood monocytes and exhibit an IL-10(high)IL-12(low) M2 profile. The factors involved in TAM generation remain unidentified. We identify here leukemia inhibitory factor (LIF) and IL-6 as tumor microenvironmental factors that can promote TAM generation. Ovarian cancer ascites switched monocyte differentiation into TAM-like cells that exhibit most ovarian TAM functional and phenotypic characteristics. Ovarian cancer ascites contained high concentrations of LIF and IL-6. Recombinant LIF and IL-6 skew monocyte differentiation into TAM-like cells by enabling monocytes to consume monocyte-colony-stimulating factor (M-CSF). Depletion of LIF, IL-6, and M-CSF in ovarian cancer ascites suppressed TAM-like cell induction. We extended these observations to different tumor-cell line supernatants. In addition to revealing a new tumor-escape mechanism associated with TAM generation via LIF and IL-6, these findings offer novel therapeutic perspectives to subvert TAM-induced immunosuppression and hence improve T-cell-based antitumor immunotherapy efficacy.
引用
收藏
页码:4319 / 4330
页数:12
相关论文
共 68 条
[41]   The unsolved enigmas of leukemia inhibitory factor [J].
Metcalf, D .
STEM CELLS, 2003, 21 (01) :5-14
[42]   Leukemia inhibitory factor is linked to regulatory transplantation tolerance [J].
Metcalfe, SM ;
Watson, TJ ;
Shurey, S ;
Adams, E ;
Green, CJ .
TRANSPLANTATION, 2005, 79 (06) :726-730
[43]   Targeting the mechanisms of tumoral immune tolerance with small-molecule inhibitors [J].
Muller, Alexander J. ;
Scherle, Peggy A. .
NATURE REVIEWS CANCER, 2006, 6 (08) :613-625
[44]   Indoleamine 2,3-dioxygenase and tumor-induced tolerance [J].
Munn, David H. ;
Mellor, Andrew L. .
JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (05) :1147-1154
[45]   Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes [J].
Munn, DH ;
Sharma, MD ;
Hou, D ;
Baban, B ;
Lee, JR ;
Antonia, SJ ;
Messina, JL ;
Chandler, P ;
Koni, PA ;
Mellor, AL .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (02) :280-290
[46]   Inhibition of T cell proliferation by macrophage tryptophan catabolism [J].
Munn, DH ;
Shafizadeh, E ;
Attwood, JT ;
Bondarev, I ;
Pashine, A ;
Mellor, AL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (09) :1363-1372
[47]  
Oyama T, 1998, J IMMUNOL, V160, P1224
[48]   PTX3, a prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans [J].
Peri, G ;
Introna, M ;
Corradi, D ;
Iacuitti, G ;
Signorini, S ;
Avanzini, F ;
Pizzetti, F ;
Maggioni, AP ;
Moccetti, T ;
Metra, M ;
Dei Cas, L ;
Ghezzi, P ;
Sipe, JD ;
Re, G ;
Olivetti, G ;
Mantovani, A ;
Latini, R .
CIRCULATION, 2000, 102 (06) :636-641
[49]   T-cell cytokines in pregnancy [J].
Piccinni, MP .
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2002, 47 (05) :289-294
[50]   Tumour-educated macrophages promote tumour progression and metastasis [J].
Pollard, JW .
NATURE REVIEWS CANCER, 2004, 4 (01) :71-78